Masako Shida

941 total citations
36 papers, 458 citations indexed

About

Masako Shida is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Masako Shida has authored 36 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Obstetrics and Gynecology, 12 papers in Reproductive Medicine and 9 papers in Molecular Biology. Recurrent topics in Masako Shida's work include Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Uterine Myomas and Treatments (7 papers). Masako Shida is often cited by papers focused on Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Uterine Myomas and Treatments (7 papers). Masako Shida collaborates with scholars based in Japan, United States and Italy. Masako Shida's co-authors include Mikio Mikami, Masae Ikeda, Takeshi Hirasawa, Koji Matsuo, Masanori Yasuda, Masaru Murakami, Akane Kondo, Takahiro Suzuki, Shun‐ichiro Izumi and Hidehiko Matsubayashi and has published in prestigious journals such as PLoS ONE, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Masako Shida

36 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Shida Japan 13 192 189 67 61 58 36 458
E Sun Paik South Korea 15 224 1.2× 268 1.4× 119 1.8× 28 0.5× 97 1.7× 42 556
Tamara Kalir United States 11 271 1.4× 243 1.3× 87 1.3× 57 0.9× 71 1.2× 23 545
Yasushi Iida Japan 12 175 0.9× 365 1.9× 191 2.9× 66 1.1× 148 2.6× 31 668
Bradley R. Corr United States 14 210 1.1× 202 1.1× 154 2.3× 89 1.5× 246 4.2× 64 699
Seyran Yiğit Türkiye 14 55 0.3× 95 0.5× 76 1.1× 62 1.0× 181 3.1× 43 433
Iwona Podzielinski United States 10 309 1.6× 492 2.6× 164 2.4× 58 1.0× 148 2.6× 18 768
Miriam Rottmann Germany 11 55 0.3× 80 0.4× 116 1.7× 43 0.7× 197 3.4× 23 526
Moon‐Hong Kim South Korea 17 505 2.6× 274 1.4× 117 1.7× 44 0.7× 167 2.9× 30 841
Hirokuni Takano Japan 12 137 0.7× 241 1.3× 316 4.7× 20 0.3× 123 2.1× 37 758
Alvaro Ingles Garces United Kingdom 13 50 0.3× 45 0.2× 171 2.6× 66 1.1× 200 3.4× 29 445

Countries citing papers authored by Masako Shida

Since Specialization
Citations

This map shows the geographic impact of Masako Shida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Shida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Shida more than expected).

Fields of papers citing papers by Masako Shida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Shida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Shida. The network helps show where Masako Shida may publish in the future.

Co-authorship network of co-authors of Masako Shida

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Shida. A scholar is included among the top collaborators of Masako Shida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Shida. Masako Shida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shida, Masako, Jun Ito, Yuki Inoue, et al.. (2025). Dimethyl sulfoxide–induced DNA demethylation during vitrification of early cleavage-stage embryos and possible countermeasures. Journal of Assisted Reproduction and Genetics. 42(4). 1275–1286. 1 indexed citations
2.
Machida, Hiroko, Hiroshi Yoshida, Kenji Izumi, et al.. (2021). Surgical approach in early stage cervical cancer: the Asian view point. European Journal of Gynaecological Oncology. 42(1). 30–30. 4 indexed citations
3.
4.
5.
Matsuo, Koji, Marianne S. Hom, Akira Yabuno, et al.. (2019). Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer. Gynecologic Oncology. 152(3). 605–611. 7 indexed citations
6.
Matsuo, Koji, Akira Yabuno, Marianne S. Hom, et al.. (2018). Significance of abnormal peritoneal cytology on survival of women with stage I–II endometrioid endometrial cancer. Gynecologic Oncology. 149(2). 301–309. 38 indexed citations
7.
Iwase, Haruko, Takeshi Hirasawa, Hidetaka Sato, et al.. (2018). The Clinical Features of Recurrent EndometrialCancer in Japan. International Journal of Gynecological Cancer. 28(8). 1616–1623. 9 indexed citations
8.
Mikami, Mikio, Masako Shida, Hidetaka Katabuchi, et al.. (2017). Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer. Journal of Gynecologic Oncology. 29(2). e23–e23. 25 indexed citations
9.
10.
Tajima, T., Masaki Miyazawa, Masaru Hayashi, et al.. (2016). Enhanced expression of hydroxylated ceramide in well-differentiated endometrial adenocarcinoma. Oncology Letters. 13(1). 45–50. 3 indexed citations
11.
Matsuo, Koji, Kosuke Yoshihara, Masako Shida, et al.. (2016). Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer. Obstetrics and Gynecology. 128(1). 127–137. 35 indexed citations
12.
Mikami, Mikio, Kazuhiro Tanabe, Koji Matsuo, et al.. (2015). Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma. Gynecologic Oncology. 139(3). 520–528. 22 indexed citations
13.
Ikeda, Masae, Masaru Hayashi, Masako Shida, et al.. (2014). Predicting Perioperative Venous Thromboembolism in Japanese Gynecological Patients. PLoS ONE. 9(2). e89206–e89206. 7 indexed citations
14.
Hirasawa, Takeshi, Masaki Miyazawa, Masanori Yasuda, et al.. (2013). Alterations of Hypoxia-Induced Factor Signaling Pathway Due to Mammalian Target of Rapamycin (mTOR) Suppression in Ovarian Clear Cell Adenocarcinoma. International Journal of Gynecological Cancer. 23(7). 1210–1218. 8 indexed citations
15.
Murakami, Masaru, et al.. (2009). 18F-Fluorodeoxyglucose uptake in uterine leiomyomas in healthy women. Clinical Imaging. 33(6). 462–467. 3 indexed citations
16.
Murakami, Masaru, Masako Shida, Takeshi Hirasawa, et al.. (2006). Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas. International Journal of Gynecological Cancer. 16(2). 854–860. 32 indexed citations
17.
Murakami, Masaru, Tadayoshi Miyamoto, Taku Iida, et al.. (2006). Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. International Journal of Gynecological Cancer. 16(S1). 99–107. 41 indexed citations
18.
Shida, Masako, et al.. (2006). F-18 fluorodeoxyglucose uptake in leiomyomatous uterus. International Journal of Gynecological Cancer. 17(1). 285–290. 24 indexed citations
19.
Matsubayashi, Hidehiko, Masako Shida, Akane Kondo, et al.. (2005). Preconception Peripheral Natural Killer Cell Activity as a Predictor of Pregnancy Outcome in Patients with Unexplained Infertility. American Journal of Reproductive Immunology. 53(3). 126–131. 30 indexed citations
20.
Arai, Tsunetaka, Hidehiko Matsubayashi, Toshitaka Sugi, et al.. (2003). Anti‐annexin A5 Antibodies in Reproductive Failures in Relation to Antiphospholipid Antibodies and Phosphatidylserine. American Journal of Reproductive Immunology. 50(3). 202–208. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Sun Paik Breakdown of academic impact, for papers by Tamara Kalir Breakdown of academic impact, for papers by Yasushi Iida Breakdown of academic impact, for papers by Bradley R. Corr Breakdown of academic impact, for papers by Seyran Yiğit Breakdown of academic impact, for papers by Iwona Podzielinski Breakdown of academic impact, for papers by Miriam Rottmann Breakdown of academic impact, for papers by Moon‐Hong Kim Breakdown of academic impact, for papers by Hirokuni Takano Breakdown of academic impact, for papers by Alvaro Ingles Garces
Rankless by CCL
2026